Cytogen 356

Known as: CYT 356, CYT-356 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Capromab Pendetide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy.
OBJECTIVES The sites of recurrent carcinoma of the prostate were localized with radiolabeled monoclonal antibody, and these sites… (More)
Is this relevant?
1997
1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients.
BACKGROUND Stored serum from clinical trial cases undergoing ProstaScint (CYT-356) scanning were available for Prostate Specific… (More)
Is this relevant?
1997
1997
Monoclonal antibody 7E11.C5 staining of viable LNCaP cells.
BACKGROUND Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein defined by the monoclonal antibody 7E11.C5… (More)
Is this relevant?
1996
1996
Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
1996
1996
Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation.
The utility of monoclonal antibody (MAb) imaging for detection of occult recurrent prostate cancer was investigated in 14… (More)
Is this relevant?
1995
1995
Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.
Prostate-specific membrane antigen (PSMA) is a trans-membrane glycoprotein recognized by the murine monoclonal antibody (MAb… (More)
Is this relevant?
1995
1995
Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen.
The expression of the prostate-specific membrane antigen (PSMA) glycoprotein recognized by the murine monoclonal antibody (MAb… (More)
Is this relevant?
1994
1994
Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356.
In an attempt to define the possible role of radioimmunoscintigraphy to assess noninvasively the pelvic lymph nodes, we studied… (More)
Is this relevant?
1994
1994
Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence.
We assessed the safety and ability of the 111indium labeled immunoconjugate 7E11-C5.3-glycyl-tyrosyl-(N,e… (More)
Is this relevant?
1990
1990
Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
In this study, a site-specific immunoconjugate, designated CYT-356, of the prostate-reactive monoclonal antibody 7E11-C5 was… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?